International Journal of Pharmaceutical Sciences
When tirzepatide binds to albumin in your blood, it is shielded from enzymatic breakdown and renal filtration
The team determined that starting tirzepatide treatment was associated with a lower 12-month risk of incident mild nonproliferative DR (NPDR) and with fewer vision-threatening events, proliferative DR (DR), diabetic macular edema (DME), vitreous hemorrhage, tractional retinal detachment and need for intravitreal anti-VEGF or panretinal photocoagulation
Perspective Back to Top Nonarteritic anterior ischemic optic neuropathy (NAION) is rare, affecting between two and 10 people per 100,000 in the general population
For external use only.
There is also a possibility that the included studies reporting null or negative associations may be underrepresented in the published literature, leading to an overestimation of the observed association between GLP-1 RAs and CRC susceptibility